OBN: Supporting the UK’s Emerging Life Science Companies

OBN is the membership organisation supporting and bringing together the UK's emerging life science companies, corporate partners and investors. Our 220 member companies are located across the Golden Triangle and beyond, and benefit from our networking, partnering, purchasing, advising, and advocacy activities. OBN organises BioTrinity 2013 - Europe's Premier Biopartnering and Investment Conference attracting 850 delegates (May 14-16).

	Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) - 2013-05-22
	InterPharm Investments appoints Danilo Casadei Massari to Board of Directors - 2013-05-22
	Competition Launched to Select the Hottest Five Emerging Companies in the Digital Health Space - 2013-05-21
	Precious Metal Recovery Specialist, PhosphonicS, Appoints Linda Bell as Chief Executive Officer - 2013-05-20

	2013-05-30 - OBN BioThirstday
	2013-06-06 - OBN Senior Executive Breakfast Club: What's on the Horizon 2020? - London (Invitation Only)
	2013-06-11 - OBN 2013 Annual Biotech Senior Executive Dinner (Invitation-only)
	2013-06-18 - OBN PharmaTuesday:
	2013-06-20 - OBN Senior Executive Breakfast Club (Invitation only) Oxford

	2013-05-29 - ChinaBio® Partnering Forum 2013
	2013-05-30 - OBN BioThirstday

OBN: Supporting the UK’s Emerging Life Science Companies !function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0];if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src="//platform.twitter.com/widgets.js";fjs.parentNode.insertBefore(js,fjs);}}(document,"script","twitter-wjs");

OBN: Supporting the UK’s Emerging Life Science Companies